← Evidence map

ArticleMarine drugs2014

Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.

Jia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25257790